All Episodes

Updates for T1D Treatment in Pregnancy and Pediatrics

Nutrition, Medication, and Treatment in Obesity With Elizabeth Bauer, MD

The Push for Early-Stage T1D Screening and Treatment, With Linda DiMeglio, MD, MPH

Orforglipron Availability, Amazon Pharmacy, and Dosing Considerations

The G7 15-Day System and CGM Innovations at Dexcom, With Jessica Castle, MD

FDA Approves Novo Nordisk’s Insulin Icodec-abae (Awiqli) for T2D

2026 AACE Guidelines for Type 2 Diabetes

Orforglipron Receives FDA Approval for Chronic Weight Management

Q1 2026 Updates from Tandem Diabetes Care, with Laurel Messer, PhD, RN

ATTD 2026 Recap

Orforglipron, Retatrutide, and Other GLP-1 Updates

Launch of the Zepbound KwikPen

Implantable Insulin Pumps and Interoperability

Oral Ozempic and the Risks of Compounding Formulas

Tech Updates on Twiist, MiniMed Go, and More

Reviewing the New US Dietary Guidelines with Susan Weiner, MS

Therapeutic Updates from the ADA 2026 Standards of Care

Orforglipron, Cagrilintide, and the Libre Assist

2026 Technology Updates and American Diabetes Association Standards of Care

Reacting to Retatrutide and TRIUMPH-4 Topline Data

Semaglutide Falls Short in Alzheimer Disease, Tirzepatide Shows Promise in T1D

Updates on Dexcom G7 and Semaglutide Pricing

Oral Semaglutide and SELECT at DTM 2025

Biolinq Shine, Insulin Icodec, and Eli Lilly's Pipeline

Celebrating 150 Episodes!

What's New at Medtronic Diabetes With Bob Vigersky, MD

Results of ATTAIN-1 and STEP UP Phase 3 Trials

Milestones for MiniMed 780G and Signos CGM for Weight Loss

Semaglutide & Tirzepatide Updates at ESC Congress 2025

FDA Approves Semaglutide (Wegovy) for MASH

ADCES 2025 Part 3 & Diabetes Tech Updates

ADCES 2025 Recap Part 2

Orforglipron Topline Results & ADCES 2025 Part 1

Tirzepatide and SURPASS-CVOT Topline Results

Guideline Updates for Diabetes & Pregnancy

GLP-1s, SGLT2s, and Diabetes Barbie at ENDO 2025

Upcoming Research on Type 1 Diabetes in Pregnancy with Carol Levy, MD

BELIEVE, GLP-1/GIP Agonists, and CATALYST Results at ADA 2025

American Diabetes Association 2025 Trial Recap - Part 1

The Diabetes Collective, with Rachael Sood, RN, MSN, APRN

Addressing America's Shortage of Diabetes Care Providers, with Jay Shubrook, DO, & Conan Tu, MD

CATALYST Trial, Mifepristone, and Hypercortisolism in T2D, with John Buse, MD, PhD

Updates from Dexcom at ADA 2025, with Kevin Sayer

REDEFINE 1 and REDEFINE 2, with Timothy Garvey, MD, and Melanie Davies, MD

ADA 2025 Preview

American Diabetes Association Consensus Report on MASLD

May 2025 Diabetes Tech & Breakthrough T1D Updates

INHALE-3 Trial and Afrezza, With Roy Beck, MD, PhD

Diabetes Dialogue: AACE 2025 Recap

Real-World Impact of iLet Bionic Pancreas, With Steven Russell, MD, PhD

Luna Automated Insulin Delivery, With Jon Brilliant and John Sjölund

Tirzepatide vs Semaglutide for Obesity, Understanding SURMOUNT-5

Diabetes Dialogue: Dexcom G7, Libre App, and Medtronic Simplera Sync

Diabetes Dialogue: Semaglutide for MASH in ESSENCE Trial, With Arun Sanyal, MD

Diabetes Dialogue: CATALYST Reveals High Prevalence of Hypercortisolism in T2D

Diabetes Dialogue: Oral GLP-1 Orforglipron in ACHIEVE-1 Trial

SCORE, Semaglutide, and ACC Wrap-up

Diabetes Dialogue: Screening for Presymptomatic T1D with Rifka Schulman-Rosenbaum, MD

Diabetes Dialogue: SOUL and STRIDE Trials from ACC 2025

Diabetes Dialogue: Updates and News from ATTD 2025 Part 1

Bionic Pancreas Brings AID to Primary Care & Telehealth

Diabetes Dialogue: Understanding Control-IQ+ AID Algorithm with Laurel Messer, PhD, RN

Impact of NovoCare Pharmacy, LillyDirect Self Pay on GLP-1 RA Access

1: News and Updates in Diabetes Care from February 2025

Omnipod 5 and Medtronic 780G for Type 2 Diabetes

Understanding Semaglutide (Ozempic) in CKD and T2D

ADA’s 2025 Standards of Care in Diabetes Therapeutics

ADA’s 2025 Standards of Care in Diabetes Technology

The Evolving Role of Registered Dietitian Nutritionists in Obesity

Leveraging Smart Algorithms for Insulin Optimization with Eran Atlas

Insights on INHALE-1 and CATALYST Trials

Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss

Diabetes Dialogue: Celebrating 2024 - The Year of the Continuous Glucose Monitor

Celebrating 25 Years of CGM, with Irl Hirsch, MD

News and Updates in Diabetes at AHA 2024

Tirzepatide’s Long-Term Obesity Data

Latest Updates on Semaglutide

Diabetes Tech Updates in October 2024

What to Know About the Eversense 365 CGM, with Brian Hansen

Lingo Availability & Embecta's Tubeless Patch Pump

Real-World Experience with Dexcom Stelo

Sotagliflozin for T1D and Other ADCES Highlights

First 10 Prices Announced from CMS Price Negotiations

Navigating ADCES 2024

SUMMIT and FINEARTS-HF, with Muthiah Vaduganathan, MD, MPH

Simplera CGM and Medtronic's Partnership with Abbott

CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD

New Early-Stage T1D Monitoring Guidance, with Anastasia Albanese-O'Neill, PhD, APRN

INHALE-3 and Diabetes Tech Updates, with Grazia Aleppo, MD

Blue Circle Health, with Monica Gomberg, MD

Advances in AID and CGM at ADA 2024, with Davida Kruger, NP

ADA Introduces Obesity Association, with Robert Gabbay, MD, PhD

Patient Considerations for Inhaled Insulin, with Carol Levy, MD

ADA 2024 Diabetes Technology Recap

June 2024 Updates in Diabetes Technology and T1D

GLAM and CRISTAL, Updates in Pregnancy

FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease

2024 ACP Type 2 Diabetes Recommendations

STEP HFpEF DM and Fair Allocation of Incretin-Based Therapies

What to Know about Sequel Med Tech's twiist AID System, with Alan Lotvin, MD

Hot Topics and Updates from ATTD 2024

T1D Glycemic Improvement and CRISTAL at ATTD 2024

FLOW Trial and Chronic Kidney Disease Updates, with Brendon Neuen, MBBS, PhD

Dexcom Stelo and CGM Updates, with Jake Leach

Tirzepatide and the Future of Incretin Therapies, with Timothy Garvey, MD

SELECT, Semaglutide, & the Future of Incretin Therapies, with A. Michael Lincoff, MD

Understanding MARD, Comparing Popular CGM Sensors

ATTD 2024 Preview

Time in Range, CGM Metrics for Predicting Outcomes in Diabetes

Tirzepatide in Type 1 Diabetes, with Viral Shah, MD

Diabetes Technology Updates in January 2024

Updates in Management of Hypercortisolism in Type 2 Diabetes, with Ralph DeFronzo, MD

Latest Updates on Diabetes Management in Pregnancy

Baricitinib & the Potential Disease-Modifying Therapies in Type 1 Diabetes

Diabetes Dialogue: 2023 Top Episodes Recap

Key Updates in ADA Standards of Care—2024

Diabetes Technology Updates and Standards of Care—2024

SELECT Proves Semaglutide 2.4 mg CV Benefit at AHA 2023

Tirzepatide (Zepbound) Approved for Chronic Weight Management

Diabetes Dialogue: Automated Insulin Delivery News in October 2023

SURMOUNT-3 and SURMOUNT-4 Data

PROTECT Data and Teplizumab in Newly Diagnosed T1D

Accu-Chek Solo and Abbott Acquiring Bigfoot Biomedical

Making Sense of Semaglutide in Type 1 Diabetes

Clearance of Tandem Mobi and Welldoc's BlueStar Platform

Addressing Health Disparities with Diabetes Technology, with Etty Vider, PharmD

What Medicare Drug Price Negotiations Mean for Diabetes

Diabetes Dialogue: The Role of Nutrition in Diabetes Management, with Dawn Noe, RDN, LD

Diabetes Dialogue: Implications of SELECT Trial and Brenzavvy on Cost Plus Drugs

Diabetes Dialogue: ADCES 2023 Recap

Diabetes Dialogue: ADA 2023 Recap

Diabetes Dialogue: Latest News in Insulin Delivery, with Gary Scheiner, MS

Diabetes Dialogue: Embracing Diabetes Tech and Social Media as a Clinician, with David Ahn, MD

Diabetes Dialogue: Establishing Time in Range as a Primary Glucose Metric

Diabetes Dialogue: TRANSITION-T2D, with Paloma Rodriguez, MD, and Kevin Pantalone, DO

Diabetes Dialogue: "Second-Generation" Obesity Medications, with W. Timothy Garvey, MD

Diabetes Dialogue: Improving Implementation of New Technology, with Cari Berget, RN, MPH

Diabetes Dialogue: Managing & Addressing Mental Health Needs in Diabetes

Diabetes Dialogue: Reforming Language in Metabolic Disease, with Jane Dickinson, RN, PhD

Diabetes Dialogue: Diabetic Foot Ulcers and Social Determinants of Health

Diabetes Dialogue: What to Know about the iLet Bionic Pancreas

Diabetes Dialogue: Breaking Down AACE's New Type 2 Diabetes Management Algorithms

Diabetes Dialogue: Breaking Down the Medtronic 780G Approval, with Robert Vigersky, MD

Diabetes Dialogue: SURMOUNT-2 Reaction, Omnipod GO, and Verapamil for T1D

Diabetes Dialogue: CMS Expansion Ushers in New Age of CGM Access

Diabetes Dialogue: ATTD 2023 Recap

Diabetes Dialogue: Practical Updates in Pediatric Diabetes, with Stuart Weinzimer, MD

Diabetes Dialogue: Technology Guidelines and Uptake in Diabetes, with Grazia Aleppo, MD

Diabetes Dialogue: The Role of Patient Voice in Diabetes Management

Diabetes Dialogue: Actualizing the Optimal Role of Inhaled Insulin, with Joanne Rinker, MS, RDN

Diabetes Dialogue: Updates in Diabetes Management from ATTD 23, with Irl Hirsch, MD

Diabetes Dialogue: Screenings for Hearing Loss in Diabetes, with Joanne Rinker, MS, RDN

Diabetes Dialogue: Mental Health and PRO Standardization, with Katharine Barnard-Kelly, PhD

Diabetes Dialogue: FDA Clearance of Tidepool Loop

Diabetes Dialogue: ADCES DTC 22, with Jennifer Okemah, RD, and Gary Scheiner, MS

Diabetes Dialogue: The Prospect of a Bionic Pancreas, with Steven Russell, MD, PhD

Diabetes Dialogue: December 2022

Diabetes Dialogue: The Psychology of Diabetes Management, with Jill Weissberg-Benchell, PhD

Diabetes Dialogue: Updates in Inpatient Management of Diabetes, with Jane Jeffrie Seley, DNP, MPH

Diabetes Dialogue: What Teplizumab Means for Type 1 Diabetes

Diabetes Dialogue: Obesity Updates, with Lydia Alexander, MD

Diabetes Dialogue: GLP-1 RA Shortage & ADA/KDIGO Recommendations

Diabetes Dialogue: EASD 2022 and Recent CGM News

Diabetes Dialogue: September 2022

Diabetes Dialogue: ADCES 2022 Recap

Diabetes Dialogue: Updates in Diabetes Management at ADCES, with Jennifer Clements, PharmD

Diabetes Dialogue: Sit Down with Diabetes Care and Education Specialist of the Year, Anastasia Albanese-O'Neill, PhD

Diabetes Dialogue: T1D Exchange, with David Walton

Diabetes Dialogue: Exploring DiabetesWise, with Korey Hood, PhD

Diabetes Dialogue: The Race to Cure T1D

Diabetes Dialogue: Prescribing Tirzepatide, Biosimilar Insulins, & Misdiagnosis of T1D

Diabetes Dialogue: Inside ADA 2022

Diabetes Dialogue: Inequities & Barriers in Diabetes, with Jasmine Gonzalvo, PharmD

Diabetes Dialogue: Frontline Perspective from ADA 2022, with Gary Scheiner, MS, CDE

Diabetes Dialogue: Optimizing CGM Uptake in Primary Care

Diabetes Dialogue: Tirzepatide in Action & AACE 2022 Recap

Diabetes Dialogue: ATTD 2022 Recap

Diabetes Dialogue: April 2022

Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives

Semaglutide 2.4 mg (Wegovy):A Turning Point for Obesity

Subcutaneous Semaglutide for Weight Loss with Thomas Wadden, PhD

Tirzepatide for Weight Loss and Lowering HbA1c with Juan Frias, MD

Dietary Interventions and the Role of Nutrition in Obesity with Ariana Chao, PhD, CRNP

Jeffrey Curtis, MD: Osteoporosis in 2020

Osilodrostat and Treatment of Cushing's Disease

Terri Lipman, PhD, CRNP: Addressing Racial Disparities in Medicine

Raymond Douglas, MD, PhD: State of Thyroid Eye Disease in 2020

Muthiah Vaduganathan, MD: Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1 RAs

Prof. Hiddo Heerspink: Insights from DAPA-CKD

Joshua Denson, MD: Metabolic Syndrome and COVID-19 Outcomes

Robert Busch, MD: Topline Results of EMPEROR-REDUCED

Diabetes Research & COVID-19